LOADING
Comparing Johnson & Johnson (JNJ) and Pfizer Inc (PFE), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $623.3B | $160.3B |
| P/E Ratio | 30.7 | 37.0 |
| Forward P/E | 21.0 | 9.7 |
| PEG Ratio | 2.82 | 12.89 |
| EPS | $8.43 | $0.76 |
| Revenue Growth (YoY) | 6.6% | 2.6% |
| Profit Margin | 21.5% | 6.8% |
| Return on Equity | 25.7% | 5.0% |
| Dividend Yield | 1.98% | 6.03% |
| Beta | 0.23 | 0.30 |
| 52-Week High | $281.07 | $29.21 |
| 52-Week Low | $178.89 | $22.57 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.